LA Private

August 2024

News Corp eyes Foxtel sale again

For a second year, Murdoch clan-owned News Corp is considering whether to sell its 65%-owned pay TV business, Foxtel. The company, which reported its fourth-quarter and 2023-24 results on Thursday, also revealed that the Foxtel review came after receiving “third-party” interest in the business. It did not say who the interest was from, but some […]

News Corp eyes Foxtel sale again Read More »

Webjet to demerge

Of course, the splitting of Webjet (ASX:WEB) into two companies is going to be a good thing – you don’t have to read the 214-page explanatory document to know that. Why else would Webjet release the independent expert’s report with its recommendation to back the split, along with a notice of meeting for shareholders to

Webjet to demerge Read More »

IGO turns nickel into gold

We saw the mining equivalent of alchemy on Thursday in a deal revealed by IGO (ASX:IGO) and gold tiddler Medallion Metals (ASX:MM8). IGO has a review of its future underway, and on Thursday it made its choice quite clear when it revealed a deal to sell its dying nickel assets at Forrestania in WA. This

IGO turns nickel into gold Read More »

Myer profit down nearly 30%

Department store retailer Myer (ASX:MYR) has warned it will report a significant fall in profit for the year to July 31. The retailer told the ASX in an update on Thursday that net profit after tax will be down close to 30%, despite only a small dip in sales to around $3.2 billion for the

Myer profit down nearly 30% Read More »

Stocks of the Hour: NOVONIX, Cynata Therapeutics, Cauldron Energy

To register for Friday’s webinar click here. NOVONIX (ASX:NVX) and CBMM has joined forces to develop cost-effective, high-performance cathode materials. NOVONIX’s patented process will combine with CBMM’s niobium to create high-performance, low-cost batteries. Shares are trading 0.81 per cent lower at 61 cents. Cynata Therapeutics (ASX:CYP) announces positive preclinical results for Cymerus™ therapy in pulmonary

Stocks of the Hour: NOVONIX, Cynata Therapeutics, Cauldron Energy Read More »

ASX down 0.62% near noon: Materials down 1.95 per cent

At 11:30am, the S&P/ASX 200 is 0.62 per cent lower at 7,652.40. The Australian sharemarket is trading lower, mirroring a decline in US markets following a poorly received Treasury bond auction. Investors are anticipating increased volatility in the coming weeks as they await key economic data releases. Several individual stocks experienced significant price movements due

ASX down 0.62% near noon: Materials down 1.95 per cent Read More »

Transurban to boost dividend

Toll road operator, Transurban (ASX:TCL), is looking to boost its 2024-25 distribution to 65 cents per security from 62 cents for the year just ended. The 4.8% improvement will be above the expected rate of inflation but lower than the near 7% (and inflation-beating) rise in 2022-23. The company told the ASX on Thursday that

Transurban to boost dividend Read More »

China’s import tale

Chinese imports surprised by being stronger than forecast in June, rising 7.2% instead of the predicted 3.5% and more than reversing the previous month’s decline. While iron ore and coal remained robust, copper was a concern, and oil was also troubling, with the smallest daily import volume in two years. This suggests that the property

China’s import tale Read More »